ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 109 filers reported holding ALX ONCOLOGY HLDGS INC in Q4 2021. The put-call ratio across all filers is 3.95 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $412,243 | -9.3% | 85,884 | +41.9% | 0.00% | – |
Q2 2023 | $454,423 | +341.8% | 60,509 | +165.9% | 0.00% | – |
Q1 2023 | $102,853 | -45.7% | 22,755 | +35.4% | 0.00% | – |
Q4 2022 | $189,336 | -36.9% | 16,800 | -46.5% | 0.00% | – |
Q3 2022 | $300,000 | -46.8% | 31,400 | -54.9% | 0.00% | – |
Q2 2022 | $564,000 | -62.7% | 69,693 | -22.1% | 0.00% | – |
Q1 2022 | $1,512,000 | -53.8% | 89,512 | -41.2% | 0.00% | – |
Q4 2021 | $3,274,000 | -42.2% | 152,340 | +98.5% | 0.00% | – |
Q3 2021 | $5,669,000 | +106.6% | 76,752 | +53.0% | 0.00% | – |
Q2 2021 | $2,744,000 | -38.4% | 50,161 | -17.0% | 0.00% | – |
Q1 2021 | $4,457,000 | +61.7% | 60,450 | +89.1% | 0.00% | – |
Q4 2020 | $2,756,000 | – | 31,964 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
venBio Partners LLC | 9,699,925 | $530,392,000 | 62.60% |
Logos Global Management LP | 3,156,981 | $172,624,000 | 14.51% |
Vivo Capital, LLC | 4,220,048 | $230,752,000 | 9.99% |
Foresite Capital Management V, LLC | 231,200 | $12,642,000 | 4.97% |
Cormorant Asset Management, LP | 889,454 | $48,635,000 | 1.65% |
Board of Trustees of The Leland Stanford Junior University | 259,982 | $14,216,000 | 1.33% |
Redmile Group, LLC | 914,035 | $49,979,000 | 0.74% |
SPHERA FUNDS MANAGEMENT LTD. | 192,728 | $10,538,000 | 0.71% |
Financial Advisory Group | 54,041 | $2,955,000 | 0.71% |
Nan Fung Group Holdings Ltd | 34,950 | $1,911,000 | 0.59% |